JP2022516461A5 - - Google Patents

Info

Publication number
JP2022516461A5
JP2022516461A5 JP2021537725A JP2021537725A JP2022516461A5 JP 2022516461 A5 JP2022516461 A5 JP 2022516461A5 JP 2021537725 A JP2021537725 A JP 2021537725A JP 2021537725 A JP2021537725 A JP 2021537725A JP 2022516461 A5 JP2022516461 A5 JP 2022516461A5
Authority
JP
Japan
Prior art keywords
compound
compound according
formula
independently selected
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021537725A
Other languages
English (en)
Japanese (ja)
Other versions
JP7645546B2 (ja
JP2022516461A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/068412 external-priority patent/WO2020139857A1/en
Publication of JP2022516461A publication Critical patent/JP2022516461A/ja
Publication of JP2022516461A5 publication Critical patent/JP2022516461A5/ja
Application granted granted Critical
Publication of JP7645546B2 publication Critical patent/JP7645546B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021537725A 2018-12-28 2019-12-23 一酸化窒素放出抗菌性ポリマーおよびそれから製造された足場、ならびにそれに関する方法 Active JP7645546B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862786098P 2018-12-28 2018-12-28
US62/786,098 2018-12-28
PCT/US2019/068412 WO2020139857A1 (en) 2018-12-28 2019-12-23 Nitric oxide-releasing antibacterial polymers and scaffolds fabricated therefrom and methods pertaining thereto

Publications (3)

Publication Number Publication Date
JP2022516461A JP2022516461A (ja) 2022-02-28
JP2022516461A5 true JP2022516461A5 (enExample) 2023-01-05
JP7645546B2 JP7645546B2 (ja) 2025-03-14

Family

ID=71129297

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021537725A Active JP7645546B2 (ja) 2018-12-28 2019-12-23 一酸化窒素放出抗菌性ポリマーおよびそれから製造された足場、ならびにそれに関する方法

Country Status (7)

Country Link
US (2) US11421044B2 (enExample)
EP (1) EP3902841B1 (enExample)
JP (1) JP7645546B2 (enExample)
CN (1) CN113383019B (enExample)
AU (1) AU2019414421B2 (enExample)
CA (1) CA3124673A1 (enExample)
WO (1) WO2020139857A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109937234B (zh) 2016-10-07 2021-11-26 北卡罗来纳大学教堂山分校 S-亚硝基硫醇介导的超支化聚酯
CA3048785A1 (en) 2017-01-03 2018-07-12 The University Of North Carolina At Chapel Hill Nitric oxide-releasing alginates as biodegradable antibacterial scaffolds and methods pertaining thereto
AU2018247167B2 (en) 2017-03-28 2024-05-16 The University Of North Carolina At Chapel Hill Nitric oxide-releasing polyaminoglycosides as biodegradable antibacterial scaffolds and methods pertaining thereto
CN111491982B (zh) 2017-11-15 2023-04-18 北卡罗来纳大学查佩尔希尔分校 作为抗菌支架的一氧化氮释放型超支化化合物及其相关方法
WO2019173539A1 (en) 2018-03-06 2019-09-12 The University Of North Carolina At Chapel Hill Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds and methods pertaining thereto
JP7645546B2 (ja) 2018-12-28 2025-03-14 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル 一酸化窒素放出抗菌性ポリマーおよびそれから製造された足場、ならびにそれに関する方法
CN116574202B (zh) * 2023-04-12 2024-05-10 华南理工大学 一种含海因结构的壳聚糖双季铵盐抗菌剂及其制备方法与应用

Family Cites Families (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4169079A (en) 1977-10-24 1979-09-25 Iwao Tabushi Polystyrene based polymers containing cyclodextrin derivatives, metal complexes of the same, and process for the production of the same
US5574027A (en) 1989-11-22 1996-11-12 Bernstein; Lawrence R. Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
US5234933A (en) 1991-10-31 1993-08-10 Board Of Governors Of Wayne State University And Vanderbilt University Cyclic hydroxamic acids
DE4210332C1 (enExample) 1992-03-30 1993-07-15 Gruenenthal Gmbh, 5100 Aachen, De
US5814666A (en) 1992-04-13 1998-09-29 The United States As Represented By The Department Of Health And Human Services Encapsulated and non-encapsulated nitric oxide generators used as antimicrobial agents
US5238832A (en) 1992-06-08 1993-08-24 Board Of Governors Of Wayne State University Aryl aliphatic acids
US6200558B1 (en) 1993-09-14 2001-03-13 The United States Of America As Represented By The Department Of Health And Human Services Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US5632981A (en) 1992-08-24 1997-05-27 The United States Of America As Represented By The Department Of Health And Human Services Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US5650447A (en) 1992-08-24 1997-07-22 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Nitric oxide-releasing polymers to treat restenosis and related disorders
US5525357A (en) 1992-08-24 1996-06-11 The United States Of America As Represented By The Department Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US5405919A (en) 1992-08-24 1995-04-11 The United States Of America As Represented By The Secretary Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders
US5910316A (en) 1992-08-24 1999-06-08 The United States Of America, As Represented By The Department Of Health And Human Services Use of nitric oxide-releasing agents to treat impotency
US5691423A (en) * 1992-08-24 1997-11-25 The United States Of America As Represented By The Department Of Health And Human Services Polysaccharide-bound nitric oxide-nucleophile adducts
US5840759A (en) 1993-10-08 1998-11-24 The United States Of America As Represented By The Department Of Health And Human Services Use of nitric oxide releasing compounds to protect noncancerous cells from chemotherapeutic agents
AU685178B2 (en) 1993-10-08 1998-01-15 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Use of nitric oxide-releasing compounds as hypoxic cell radiation sensitizers
AU704173B2 (en) 1993-11-02 1999-04-15 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College, The Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
CA2205564C (en) 1994-11-22 2006-07-11 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Pharmaceutical compositions comprising nitric oxide-releasing biopolymers
US5714511A (en) 1995-07-31 1998-02-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Selective prevention of organ injury in sepsis and shock using selection release of nitric oxide in vulnerable organs
US5770645A (en) 1996-08-02 1998-06-23 Duke University Medical Center Polymers for delivering nitric oxide in vivo
US6232434B1 (en) 1996-08-02 2001-05-15 Duke University Medical Center Polymers for delivering nitric oxide in vivo
US20030093143A1 (en) 1999-03-01 2003-05-15 Yiju Zhao Medical device having surface depressions containing nitric oxide releasing compound
JP4285775B2 (ja) 1996-09-27 2009-06-24 アメリカ合衆国 O▲上2▼―アリール化またはo▲上2▼―グリコシル化1―置換ジアゼン―1―イウム―1,2―ジオレート類およびo▲上2▼―置換1―[(2―カルボキシラト)ピロリジン―1―イル]ジアゼン―1―イウム―1,2―ジオレート類
CA2266908C (en) 1996-09-27 2010-07-20 Joseph E. Saavedra O2-arylated or o2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and o2-substituted 1-[(2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates
NO305033B1 (no) 1997-05-09 1999-03-22 Algipharma As Fremgangsmate for fremstilling av uronsyreblokker fra alginat
US6180082B1 (en) 1997-11-24 2001-01-30 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Method to enhance tissue accumulation of radiolabeled compounds
US6207855B1 (en) 1998-06-23 2001-03-27 Duke University Medical Center Stable no-delivering compounds
US6261594B1 (en) 1998-11-25 2001-07-17 The University Of Akron Chitosan-based nitric oxide donor compositions
DE60136926D1 (de) 2000-05-02 2009-01-22 Theravance Inc Zusammensetzung die eine zyklodextrin und ein glykopeptid-antibiotikum enthält
JP2002179647A (ja) 2000-12-11 2002-06-26 Kikkoman Corp ニコチアナミン又はニコチアナミン含有物の製造法
AUPR879601A0 (en) 2001-11-09 2001-12-06 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
WO2003088961A1 (en) 2002-04-19 2003-10-30 Yissum Research Development Company Of The Hebrew University Of Jerusalem Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
US20040038947A1 (en) 2002-06-14 2004-02-26 The Gov. Of The U.S. Of America As Represented By The Sec. Of The Dept. Of Health & Human Services Method of treating ischemia/reperfusion injury with nitroxyl donors
NO20023581D0 (no) 2002-07-26 2002-07-26 Fmc Biopolymer As Nye mutantstammer av Pseudomonas fluorescens og varianter derav, metoder for produksjon og bruk derav til produksjon avalginat
NO335366B1 (no) 2002-07-26 2014-12-01 Algipharma As Mutantstamme Pf201 av Pseudomonas fluorescens og anvendelse derav i alginatproduksjon,samt fremgangsmåte for fremstilling derav.
KR20140070676A (ko) * 2002-09-06 2014-06-10 인설트 테라페틱스, 인코퍼레이티드 공유결합된 치료제 전달을 위한 사이클로덱스트린-기초 중합체
US20050009789A1 (en) 2003-05-13 2005-01-13 The Government Of The Usa As Represented By The Secretary Of The Dept. Of Health And Human Service Cyclooxygenase inhibition with nitroxyl
EP1648527A4 (en) * 2003-07-25 2008-04-23 Univ Akron STABILIZATION AND IONIC RELEASE OF NITRIC OXIDE RELEASE
JP2005047979A (ja) 2003-07-30 2005-02-24 Dainippon Ink & Chem Inc 多分岐ポリマーの製造方法、及び多分岐ポリマー
US20050265956A1 (en) 2004-01-12 2005-12-01 Ye Liu Polyalkyleneimine-graft-biodegradable polymers for delivery of bioactive agents
CN101151037A (zh) 2005-01-28 2008-03-26 平纳克尔医药股份有限公司 作为抗菌剂的β-环糊精衍生物
EP2669269B1 (en) 2005-05-27 2019-05-22 The University of North Carolina At Chapel Hill Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
GB0515550D0 (en) 2005-07-29 2005-09-07 Univ Strathclyde Inactivation of staphylococcus species
WO2007053292A2 (en) * 2005-10-31 2007-05-10 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Polysaccharide-derived nitric oxide-releasing carbon-bound diazeniumdiolates
JP2009523584A (ja) 2006-01-24 2009-06-25 ミリメッド・アクティーゼルスカブ Ph依存性薬物放出を有する医療デバイス
US7854923B2 (en) 2006-04-18 2010-12-21 Endomedix, Inc. Biopolymer system for tissue sealing
CN100441225C (zh) 2006-06-29 2008-12-10 上海交通大学 氨基酸改性壳聚糖亲核no供体及其合成方法
GB0707096D0 (en) 2007-04-12 2007-05-23 Ntnu Technology Transfer As Method
CN101049513B (zh) 2007-05-13 2010-05-19 刘万顺 水溶性壳聚糖基纤维止血愈创材料及其制备方法和应用
ITMI20071341A1 (it) * 2007-07-05 2009-01-06 Fidia Farmaceutici Derivati di acido ialuronico contenenti gruppi in grado di rilasciare no
WO2009049208A1 (en) 2007-10-12 2009-04-16 The University Of North Carolina At Chapel Hill Use of nitric oxide to enhance the efficacy of silver and other topical wound care agents
RU2527894C2 (ru) 2007-11-27 2014-09-10 Альгифарма ИПР АС Использование альгинатных олигомеров в борьбе с биопленками
US20090222088A1 (en) 2008-02-29 2009-09-03 Medtronic Vascular, Inc. Secondary Amine Containing Nitric Oxide Releasing Polymer Composition
US20090232863A1 (en) 2008-03-17 2009-09-17 Medtronic Vascular, Inc. Biodegradable Carbon Diazeniumdiolate Based Nitric Oxide Donating Polymers
US8841440B2 (en) 2008-04-01 2014-09-23 Cornell University Organo-soluble chitosan salts and chitosan-derived biomaterials prepared thereof
US8791245B2 (en) 2008-10-03 2014-07-29 Glycan Bioscience LLC Anionic conjugates of glycosylated bacterial metabolite
WO2010096320A2 (en) 2009-02-18 2010-08-26 Bezwada Biomedical, Llc Controlled release of nitric oxide and drugs from functionalized macromers and oligomers
GB0904941D0 (en) 2009-03-23 2009-05-06 Ntnu Technology Transfer As Composition
US8709465B2 (en) * 2009-04-13 2014-04-29 Medtronic Vascular, Inc. Diazeniumdiolated phosphorylcholine polymers for nitric oxide release
US20120107229A1 (en) 2009-04-15 2012-05-03 Xuefei Huang Novel nano-probes for molecular imaging and targeted therapy of diseases
US9539233B2 (en) 2009-05-04 2017-01-10 Aridis Pharmaceuticals Inc. Gallium formulation for the treatment and prevention of infectious diseases
GB0909557D0 (en) 2009-06-03 2009-07-15 Algipharma Ipr As Anti-microbial alginate oligomers
GB0909529D0 (en) 2009-06-03 2009-07-15 Algipharma Ipr As Alginate oligomers for the inhibition of microbial adherence to surfaces
RU2582938C2 (ru) 2009-06-03 2016-04-27 АльгиФарма АС Альгинатные олигомеры для применения в преодолении множественной лекарственной устойчивости у бактерий
US9957341B2 (en) 2009-06-09 2018-05-01 William Chambers Biodegradable absorbent material and method of manufacture
CA2671595A1 (en) 2009-07-09 2011-01-09 Ping I. Lee Controlled nitric oxide delivery from aqueous s-nitrosothiol conjugated polymers and their complexes
WO2011022652A1 (en) * 2009-08-21 2011-02-24 Novan, Inc. Topical gels
US8551456B2 (en) 2010-03-05 2013-10-08 University Of Dayton Combination therapy and methods for treating bacterial biofilms
EP2547660B1 (en) 2010-03-19 2015-01-07 The United States Of America, As Represented By The Secretary, Department of Health and Human Services Nitroxyl (hno) releasing compounds and uses thereof in treating diseases
KR101272351B1 (ko) 2010-04-23 2013-06-07 이화여자대학교 산학협력단 새로운 카나마이신 화합물, 카나마이신 생산 스트렙토마이세스 속 미생물 및 카나마이신의 생산 방법
KR101255337B1 (ko) 2010-10-04 2013-04-16 한국과학기술연구원 온도 감응성 합성 고분자를 이용한 일산화질소 전달체
EP2678041A4 (en) 2011-02-24 2015-12-23 Univ Colorado State Res Found MATERIALS FOR MODULATING BIOLOGICAL REACTIONS AND MANUFACTURING METHOD THEREFOR
US9156855B2 (en) * 2011-05-16 2015-10-13 Newsouth Innovation Pty Limited Regulation of nitric oxide release and biofilm development
ES2658897T3 (es) 2011-08-24 2018-03-12 Novan, Inc. Macromoléculas de liberación de óxido nítrico ajustables que tienen múltiples estructuras donantes de óxido nítrico
GB201116010D0 (en) 2011-09-15 2011-10-26 Algipharma As Use of alginate oligomers to enhance the effects of antifungal agents
US9017653B2 (en) 2012-06-14 2015-04-28 The Board Of Regents Of The University Of Texas System Nitric oxide-releasing compositions and methods
CN106986952B (zh) 2012-08-17 2020-03-10 北卡罗来纳大学查珀尔希尔分校 水溶性的释放一氧化氮的聚葡糖胺和其用途
WO2014138359A1 (en) 2013-03-08 2014-09-12 Allergan, Inc. Steroid antibiotic conjugates
GB201322777D0 (en) 2013-12-20 2014-02-05 Algipharma As Use of alginate oligomers as blood anticoagulants
MX2016008304A (es) 2013-12-23 2017-01-09 Norwegian Univ Of Science And Tech Usos de oligouronatos en el tratamiento de cancer.
JP2017510563A (ja) 2014-02-28 2017-04-13 アルギファルマ エーエス 嚢胞性線維症及び欠陥cftrイオンチャネル機能に関連する他の病態の治療におけるアルギネートオリゴマーの使用
KR101555523B1 (ko) * 2014-02-28 2015-09-25 부산대학교 산학협력단 산화질소 방출성 상처치료 필름 및 이의 제조방법
GB201415381D0 (en) 2014-08-29 2014-10-15 Algipharma As Inhalable powder formulations of alginate oligomers
WO2016073835A1 (en) 2014-11-06 2016-05-12 The Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods of diazeniumdiolate-based prodrugs for treating cancer
GB201504878D0 (en) 2015-03-23 2015-05-06 Algipharma As Use of alginate oligomers and CFTR modulators in the treatment of conditions associated with CFTR dysfuntion
US11170451B2 (en) 2015-10-02 2021-11-09 Not So Forgetful, LLC Apparatus and method for providing gift recommendations and social engagement reminders, storing personal information, and facilitating gift and social engagement recommendations for calendar-based social engagements through an interconnected social network
GB201517639D0 (en) 2015-10-06 2015-11-18 Algipharma As Use of alginate oligomers to treat or prevent microbial overgrowth in the intestinal tract
CN106046382B (zh) 2016-05-25 2018-10-09 暨南大学 一种装载一氧化氮的阳离子聚合物及其制备方法和应用
CN109937234B (zh) 2016-10-07 2021-11-26 北卡罗来纳大学教堂山分校 S-亚硝基硫醇介导的超支化聚酯
CA3048785A1 (en) * 2017-01-03 2018-07-12 The University Of North Carolina At Chapel Hill Nitric oxide-releasing alginates as biodegradable antibacterial scaffolds and methods pertaining thereto
AU2018247167B2 (en) 2017-03-28 2024-05-16 The University Of North Carolina At Chapel Hill Nitric oxide-releasing polyaminoglycosides as biodegradable antibacterial scaffolds and methods pertaining thereto
CN111491982B (zh) 2017-11-15 2023-04-18 北卡罗来纳大学查佩尔希尔分校 作为抗菌支架的一氧化氮释放型超支化化合物及其相关方法
WO2019173539A1 (en) 2018-03-06 2019-09-12 The University Of North Carolina At Chapel Hill Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds and methods pertaining thereto
US11102301B2 (en) 2018-07-12 2021-08-24 Sap Se PCA-based scoring of the similarity of damage patterns of operational assets
JP7645546B2 (ja) 2018-12-28 2025-03-14 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル 一酸化窒素放出抗菌性ポリマーおよびそれから製造された足場、ならびにそれに関する方法

Similar Documents

Publication Publication Date Title
JP2020504778A5 (enExample)
JP2021515083A5 (enExample)
Namivandi-Zangeneh et al. Nitric oxide-loaded antimicrobial polymer for the synergistic eradication of bacterial biofilm
CA2912690C (en) Compositions and methods for delivery of hydrophobic active agents
JP2020045493A (ja) アミン官能性ポリアミド
US20100297200A1 (en) Use of nitric oxide to enhance the efficacy of silver and other topical wound care agents
WO2011139348A9 (en) Uses of phospholipid conjugates of synthetic tlr7 agonists
JP2011528333A5 (enExample)
JP2017525676A5 (enExample)
CN1163235C (zh) 抗病毒的线性聚合物
JP2010531879A5 (enExample)
JP2011505340A5 (enExample)
JP2014512445A5 (enExample)
CN111821316A (zh) 用于免疫增强的锰组合物
US20110059040A1 (en) Compositions and methods for inhibiting viral and bacterial activity
US20260132273A1 (en) Polycationic polysaccharide and application thereof
JP2008535918A (ja) 感染性の症状を処置するための四級アンモニウムハライド
CN107496439A (zh) 一种高效安全的壳聚糖衍生物基消毒液及其制备方法
JP2022516461A (ja) 一酸化窒素放出抗菌性ポリマーおよびそれから製造された足場、ならびにそれに関する方法
JP2020515688A5 (enExample)
US20060002889A1 (en) Polyionene polymers with hydrolyzable linkages
Bertesteanu et al. Biomedical applications of synthetic, biodegradable polymers for the development of anti-infective strategies
JP2020513041A5 (enExample)
RU2018107150A (ru) Новый эффективный аминогликозидный антибиотик против бактерий с множественной лекарственной резистентностью
CN110693812A (zh) 用于增强避孕杀微生物剂有效性的组合物和方法